The Oncogene PDRG1 Is an Interaction Target of Methionine Adenosyltransferases.

Methionine adenosyltransferases MAT I and MAT III (encoded by Mat1a) catalyze S-adenosylmethionine synthesis in normal liver. Major hepatic diseases concur with reduced levels of this essential methyl donor, which are primarily due to an expression switch from Mat1a towards Mat2a. Additional changes...

Full description

Bibliographic Details
Main Authors: Claudia Pérez, Francisco J Pérez-Zúñiga, Francisco Garrido, Edel Reytor, Francisco Portillo, María A Pajares
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2016-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC4993455?pdf=render
_version_ 1818872932237049856
author Claudia Pérez
Francisco J Pérez-Zúñiga
Francisco Garrido
Edel Reytor
Francisco Portillo
María A Pajares
author_facet Claudia Pérez
Francisco J Pérez-Zúñiga
Francisco Garrido
Edel Reytor
Francisco Portillo
María A Pajares
author_sort Claudia Pérez
collection DOAJ
description Methionine adenosyltransferases MAT I and MAT III (encoded by Mat1a) catalyze S-adenosylmethionine synthesis in normal liver. Major hepatic diseases concur with reduced levels of this essential methyl donor, which are primarily due to an expression switch from Mat1a towards Mat2a. Additional changes in the association state and even in subcellular localization of these isoenzymes are also detected. All these alterations result in a reduced content of the moderate (MAT I) and high Vmax (MAT III) isoenzymes, whereas the low Vmax (MAT II) isoenzyme increases and nuclear accumulation of MAT I is observed. These changes derive in a reduced availability of cytoplasmic S-adenosylmethionine, together with an effort to meet its needs in the nucleus of damaged cells, rendering enhanced levels of certain epigenetic modifications. In this context, the putative role of protein-protein interactions in the control of S-adenosylmethionine synthesis has been scarcely studied. Using yeast two hybrid and a rat liver library we identified PDRG1 as an interaction target for MATα1 (catalytic subunit of MAT I and MAT III), further confirmation being obtained by immunoprecipitation and pull-down assays. Nuclear MATα interacts physically and functionally with the PDRG1 oncogene, resulting in reduced DNA methylation levels. Increased Pdrg1 expression is detected in acute liver injury and hepatoma cells, together with decreased Mat1a expression and nuclear accumulation of MATα1. Silencing of Pdrg1 expression in hepatoma cells alters their steady-state expression profile on microarrays, downregulating genes associated with tumor progression according to GO pathway analysis. Altogether, the results unveil the role of PDRG1 in the control of the nuclear methylation status through methionine adenosyltransferase binding and its putative collaboration in the progression of hepatic diseases.
first_indexed 2024-12-19T12:46:40Z
format Article
id doaj.art-7c390182ba054282862c25cf5b815743
institution Directory Open Access Journal
issn 1932-6203
language English
last_indexed 2024-12-19T12:46:40Z
publishDate 2016-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj.art-7c390182ba054282862c25cf5b8157432022-12-21T20:20:44ZengPublic Library of Science (PLoS)PLoS ONE1932-62032016-01-01118e016167210.1371/journal.pone.0161672The Oncogene PDRG1 Is an Interaction Target of Methionine Adenosyltransferases.Claudia PérezFrancisco J Pérez-ZúñigaFrancisco GarridoEdel ReytorFrancisco PortilloMaría A PajaresMethionine adenosyltransferases MAT I and MAT III (encoded by Mat1a) catalyze S-adenosylmethionine synthesis in normal liver. Major hepatic diseases concur with reduced levels of this essential methyl donor, which are primarily due to an expression switch from Mat1a towards Mat2a. Additional changes in the association state and even in subcellular localization of these isoenzymes are also detected. All these alterations result in a reduced content of the moderate (MAT I) and high Vmax (MAT III) isoenzymes, whereas the low Vmax (MAT II) isoenzyme increases and nuclear accumulation of MAT I is observed. These changes derive in a reduced availability of cytoplasmic S-adenosylmethionine, together with an effort to meet its needs in the nucleus of damaged cells, rendering enhanced levels of certain epigenetic modifications. In this context, the putative role of protein-protein interactions in the control of S-adenosylmethionine synthesis has been scarcely studied. Using yeast two hybrid and a rat liver library we identified PDRG1 as an interaction target for MATα1 (catalytic subunit of MAT I and MAT III), further confirmation being obtained by immunoprecipitation and pull-down assays. Nuclear MATα interacts physically and functionally with the PDRG1 oncogene, resulting in reduced DNA methylation levels. Increased Pdrg1 expression is detected in acute liver injury and hepatoma cells, together with decreased Mat1a expression and nuclear accumulation of MATα1. Silencing of Pdrg1 expression in hepatoma cells alters their steady-state expression profile on microarrays, downregulating genes associated with tumor progression according to GO pathway analysis. Altogether, the results unveil the role of PDRG1 in the control of the nuclear methylation status through methionine adenosyltransferase binding and its putative collaboration in the progression of hepatic diseases.http://europepmc.org/articles/PMC4993455?pdf=render
spellingShingle Claudia Pérez
Francisco J Pérez-Zúñiga
Francisco Garrido
Edel Reytor
Francisco Portillo
María A Pajares
The Oncogene PDRG1 Is an Interaction Target of Methionine Adenosyltransferases.
PLoS ONE
title The Oncogene PDRG1 Is an Interaction Target of Methionine Adenosyltransferases.
title_full The Oncogene PDRG1 Is an Interaction Target of Methionine Adenosyltransferases.
title_fullStr The Oncogene PDRG1 Is an Interaction Target of Methionine Adenosyltransferases.
title_full_unstemmed The Oncogene PDRG1 Is an Interaction Target of Methionine Adenosyltransferases.
title_short The Oncogene PDRG1 Is an Interaction Target of Methionine Adenosyltransferases.
title_sort oncogene pdrg1 is an interaction target of methionine adenosyltransferases
url http://europepmc.org/articles/PMC4993455?pdf=render
work_keys_str_mv AT claudiaperez theoncogenepdrg1isaninteractiontargetofmethionineadenosyltransferases
AT franciscojperezzuniga theoncogenepdrg1isaninteractiontargetofmethionineadenosyltransferases
AT franciscogarrido theoncogenepdrg1isaninteractiontargetofmethionineadenosyltransferases
AT edelreytor theoncogenepdrg1isaninteractiontargetofmethionineadenosyltransferases
AT franciscoportillo theoncogenepdrg1isaninteractiontargetofmethionineadenosyltransferases
AT mariaapajares theoncogenepdrg1isaninteractiontargetofmethionineadenosyltransferases
AT claudiaperez oncogenepdrg1isaninteractiontargetofmethionineadenosyltransferases
AT franciscojperezzuniga oncogenepdrg1isaninteractiontargetofmethionineadenosyltransferases
AT franciscogarrido oncogenepdrg1isaninteractiontargetofmethionineadenosyltransferases
AT edelreytor oncogenepdrg1isaninteractiontargetofmethionineadenosyltransferases
AT franciscoportillo oncogenepdrg1isaninteractiontargetofmethionineadenosyltransferases
AT mariaapajares oncogenepdrg1isaninteractiontargetofmethionineadenosyltransferases